0001415889-24-006428.txt : 20240304 0001415889-24-006428.hdr.sgml : 20240304 20240304193153 ACCESSION NUMBER: 0001415889-24-006428 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240229 FILED AS OF DATE: 20240304 DATE AS OF CHANGE: 20240304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Avalon Ventures XI, L.P. CENTRAL INDEX KEY: 0001652901 ORGANIZATION NAME: STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40475 FILM NUMBER: 24717637 BUSINESS ADDRESS: STREET 1: 1134 KLINE STREET CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 8583482180 MAIL ADDRESS: STREET 1: 1134 KLINE STREET CITY: LA JOLLA STATE: CA ZIP: 92037 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Avalon BioVentures I, LP CENTRAL INDEX KEY: 0001873935 ORGANIZATION NAME: STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40475 FILM NUMBER: 24717635 BUSINESS ADDRESS: STREET 1: 11099 NORTH TORREY PINES ROAD, SUITE 290 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 858-750-4700 MAIL ADDRESS: STREET 1: 11099 NORTH TORREY PINES ROAD, SUITE 290 CITY: LA JOLLA STATE: CA ZIP: 92037 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Avalon BioVentures SPV I, L.P. CENTRAL INDEX KEY: 0001844550 ORGANIZATION NAME: STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40475 FILM NUMBER: 24717636 BUSINESS ADDRESS: STREET 1: 11099 NORTH TORREY PINES ROAD, SUITE 290 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 858-750-4700 MAIL ADDRESS: STREET 1: 11099 NORTH TORREY PINES ROAD, SUITE 290 CITY: LA JOLLA STATE: CA ZIP: 92037 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Janux Therapeutics, Inc. CENTRAL INDEX KEY: 0001817713 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 822289112 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10955 VISTA SORRENTO PARKWAY STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 751-4493 MAIL ADDRESS: STREET 1: 10955 VISTA SORRENTO PARKWAY STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 form4-03052024_120347.xml X0508 4 2024-02-29 0001817713 Janux Therapeutics, Inc. JANX 0001652901 Avalon Ventures XI, L.P. 1134 KLINE STREET LA JOLLA CA 92037 false false true false 0001844550 Avalon BioVentures SPV I, L.P. 1134 KLINE STREET LA JOLLA CA 92037 0 0 1 0 0001873935 Avalon BioVentures I, LP 1134 KLINE STREET LA JOLLA CA 92037 0 0 1 0 0 Common Stock 2024-02-29 4 J 0 438722 0 D 3948495 D Common Stock 2024-02-29 4 J 0 11388 0 A 11388 I By Avalon Ventures XI GP LLC Common Stock 2024-02-29 4 J 0 11388 0 D 0 I By Avalon Ventures XI GP LLC Common Stock 2024-02-29 4 J 0 447949 0 D 4031543 I By Avalon BioVentures SPV I, LP Common Stock 2024-02-29 4 J 0 31456 0 A 31456 I By ABV SPV I GP LLC Common Stock 2024-02-29 4 J 0 31456 0 D 0 I By ABV SPV I GP LLC Common Stock 2024-02-29 4 J 0 84985 0 D 764869 I By Avalon BioVentures I, LP Common Stock 2024-02-29 4 J 0 1700 0 A 1700 I By Avalon BioVentures GP LLC Common Stock 2024-02-29 4 J 0 1700 0 D 0 I By Avalon BioVentures GP LLC Represents a pro-rata, in-kind distribution, and not a purchase or sale of securities, by Avalon Ventures XI LP (Avalon Ventures) to its general partner and limited partners without additional consideration. The shares are held directly by Avalon Ventures. Avalon Ventures XI GP, LLC (Avalon XI GP) is the general partner of Avalon Ventures and may be deemed to beneficially own the shares held by Avalon Ventures. Each of the Reporting Persons disclaims beneficial ownership of these shares except to the extent of its respective pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose. Represents receipt of shares in the distribution in kind described in footnote (1). The shares are held directly by Avalon XI GP. Avalon XI GP is the general partner of Avalon Ventures. Each of the Reporting Persons disclaims beneficial ownership of these shares except to the extent of its respective pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose. Represents a pro rata, in-kind distribution, and not a purchase or sale of securities, by Avalon XI GP to its members without additional consideration. Represents a pro rata, in-kind distribution, and not a purchase or sale of securities by Avalon BioVentures SPV I, LP (ABV SPV) to its general partner and limited partners without additional consideration. The shares are directly held by ABV SPV. ABV SPV I GP LLC (ABV SPV GP) is the general partner of ABV SPV and may be deemed to beneficially own the shares held by ABV SPV. Each of the Reporting Persons disclaims beneficial ownership of these shares except to the extent of its respective pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose. Represents receipt of shares in the distribution in kind described in footnote (6). The shares are held directly by ABV SPV GP. ABV SPV GP is the general partner of ABV SPV. Each of the Reporting Persons disclaims beneficial ownership of these shares except to the extent of its respective pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose. Represents a pro rata, in-kind distribution, and not a purchase or sale of securities, by ABV SPV GP to its members without additional consideration. Represents a pro-rata, in kind distribution, and not a purchase or sale of securities, by Avalon BioVentures I, LP (ABV I) to its general partner and limited partners without additional consideration. The shares are held directly by ABV I. Avalon BioVentures GP, LLC (ABV GP) is the general partner of ABV I and may be deemed to beneficially own the shares held by ABV I. Each of the Reporting Persons disclaims beneficial ownership of these shares except to the extent of its respective pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose. Represents receipt of shares in the distribution in kind described in footnote (11). The shares are held directly by ABV GP. ABV GP is the general partner of ABV I. Each of the Reporting Persons disclaims beneficial ownership of these shares except to the extent of its respective pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose. Represents a pro rata, in-kind distribution, and not a purchase or sale of securities, by ABV GP to its members without additional consideration. Avalon Ventures XI, L.P. By: Avalon Ventures XI GP, LLC, its general partner, By /s/ Jay B. Lichter, Authorized Signatory 2024-03-04 Avalon BioVentures SPV I, LP By: ABV SPV I GP, LLC, its general partner, By /s/ Jay B. Lichter, Authorized Signatory 2024-03-04 Avalon BioVentures I, LP By: Avalon BioVentures GP, LLC, its general partner, By /s/ Jay B. Lichter, Authorized Signatory 2024-03-04